Association between leukocyte immunoglobulin like receptor A3 and the susceptibility to inflammatory bowel disease

Xiao-min ZHANG,Feng ZHOU,Xiu-cai LAN,Mei-fang HUANG

DOI: https://doi.org/10.3870/lcxh.j.issn.1005-541X.2017.02.07

2017-01-01

Abstract:[Objective]To investigate the association between LILRA3 gene polymorphism and inflammatory bowel disease(IBD) development in Chinese Han population.[Methods]The total of 378 IBD patients(193 ulcerative colitis[UC],185 Crohn's disease[CD])and 509 healthy controls were recruited.Genotyping for LILRA3 161 base of intron 1 polymorphism(G→C mutation)was analyzed by PCR-LDR assay.qRT-PCR was employed to examine the relative mRNA levels of LILRA3 both in peripheral blood and mucosa of patients and healthy controls.The protein levels of LILRA3 in mucosa were examined by western blotting.[Results]No homozygotic mutant genotype(CC)was detected among the involved subjects.CD patients showed dramatically lower frequencies of mutant genotype GC and allele C compared with those of healthy controls(7.6％ vs 14.3％,P=0.017;3.8％ vs 7.2％,P=0.021).However,no significant difference was detected between UC and healthy controls for genotype frequency or allele frequency(P＞0.05).Genotype-phenotype analysis showed that CD patients possessing mutant genotype(GC)were less likely to develop CD between 17 to 40 years old(P=0.039,OR=0.49,95％CI:0.25-0.98),and less likely to suffer intestinal complications including stenosis and punching (P =0.049,OR =0.46,95 ％ CI:0.23-0.95).Additionally,CD and UC patients showed significantly higher LILRA3 mRNA levels compared to healthy controls both in perpheral blood([14.25±2.29],[15.71±2.74]vs[7.54±1.26],P=0.035,0.025)and in mucosa([14.31±0.88],[13.87±0.98]vs[2.29±2.88],P＜0.001).Interestingly,we found that the subjects possessing mutant genotype GC showed significantly higher LILRA3 mRNA levels than those with genotype GG([27.58±3.70]vs[10± 1.39],P＜0.001).Higher LILRA3 protein levels were also found in CD and UC patients than that of healthy controls([0.55±0.82],[0.59±0.13]vs[0.27±0.09],P＜0.001).[Conclusion]LILRA3 polymorphism of 161 base of intron 1 of LILRA3 is related with IBD susceptibility and the mutation from allele G to C affects LILRA3 expression.Elevated LILRA3 levels(mRNA and protein)are detected in blood and mucosa of both CD and UC patients compared with healthy controls.Our results suggest that LILRA3 might be a novel susceptibility gene for IBD development.